Nanobiotix S.A.

€27.00As of Sun 8 Nov 2026, 12:00 UTC
EPA:NANOHealthcare
Country France
PE (Fwd) •••
TSR 10Y CAGR 6.71%
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.54
PE TTM —
TSR TTM 50.84%
Mkt cap €1.372B
ROIC (66.69%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
€35
28.92%
(87.95%)
Hold 12|7|2|1|7
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.38
0.38
0.39
0.37
(4.97%)
(1.94%)
(4.90%)
(3.37%)
Revenue€M
70.17
72.26
72.42
70.29
8.95%
11.27%
5.65%
1.56%
Peers (US$1.540B)
Cap (US$)
PE
1.147B
—
902.0M
—
1.522B
—
Capital
TTM
5Y
10Y
Leveragex
0.747
0.398
0.390
EBIT/Intx
2.806
0.241
0.221
Own earn%
(133.06)
97.38
94.57
Sh yield%
14.40
35.66
35.73
Owners
Insiders/Inst%
3.99
26.63
Short interest%
1.00
SBC / revenue%
4.65
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
8–12
$1 testx
—
Incr. ROIC%
32